References
- KAGAYA, T., KAHWARA, A., NAGATO, S., AKASAKA, K. and KUBOT A., 1996, E2011, a novel, selective and reversible inhibitor of monoamine oxidase type A. Journal of Pharmacology and Experimental Therapeutics, 278, 243–251.
- NAITOH, T., H0R1E, T., NAGATO, S., KAGAYA, T., KUBOTA, A. and AKASAKA, K., 1994, Application of pharrnacokinetic studies to a novel antidepressant, E2011. Xenobiotica, 24, 819–826.
- NAITOH, T., MISHIMA, M., KAWAGUCHI, S., MATSUI, K., ANDOH, T., KAGEI, K., KAKIKI, M., YUZURIHA, T. and HORIE, T., 1997, Absorption, distribution, metabolism and excretion of a new, 14 C-labelled oxazolidinone MAO-A inhibitor in rat and dog. Xenobiotka, 27, 1053–1070.
- ROVEI, V., RIGAL, M., SANJUAN, M. and THIOL A., 1983, High-performance liquid chromatographic determination of cimoxatone and its O-demethyl metabolite in plasma. Journal of Chroma-tography, 277, 391–395.
- VAJTA, S., LE MOING, J. P. and ROVEI, V., 1984, Reversed-phase high-performance liquid chromato-graphic separation of '4C-labelled toloxatone and its metabolites. Journal of Chromatography, 311, 329–337.